Skip to main content
logo

Kerry Holford

Stock Analyst at Berenberg

(2.19)
# 2,819
Out of 5,122 analysts
10
Total ratings
57.14%
Success rate
13.08%
Average return
Main Sectors:
Healthcare
Top Industries:
Drug Manufacturers - General

Stocks Rated by Kerry Holford

Novo Nordisk
Sep 17, 2025
Upgrades: Buy
Price Target: n/a
Current: $47.19
Upside: -
Eli Lilly and Company
Sep 17, 2025
Downgrades: Hold
Price Target: $970 → $830
Current: $1,107.12
Upside: -25.03%